To determine the prognostic and clinical significance of G9a and c‐Myc in HCC, we examined the protein expression levels of G9a and c‐Myc in 77 HCC patient tumour specimens with matched normal adjacent tissues and known clinical follow‐up records using multispectral quantitative FIHC platform. The gene discussed is EHMT2; the disease is hepatocellular carcinoma.